Na Xu

Sorafenib maintenance in patients with FLT3-ITD acute myeloid leukaemia undergoing allogeneic haematopoietic stem-cell transplantation: an open-label, multicentre, randomised phase 3 trial

Li Xuan, Yu Wang, Fen Huang et al. · The Lancet Oncology · 2020 · 310 citations

Hematological Malignancy, Transplantation, Marrow Transplantation +10

Haploidentical transplantation might have superior graft-versus-leukemia effect than HLA-matched sibling transplantation for high-risk acute myeloid leukemia in first complete remission: a prospective multicentre cohort study

Sijian Yu, Fen Huang, Yu Wang et al. · Leukemia · 2019 · 127 citations

Superior Graft-versus-leukemia Effect, Hematological Malignancy, Transplantation +10

Olverembatinib (HQP1351), a well-tolerated and effective tyrosine kinase inhibitor for patients with T315I-mutated chronic myeloid leukemia: results of an open-label, multicenter phase 1/2 trial

Qian Jiang, Zongru Li, Ya‐Zhen Qin et al. · Journal of Hematology & Oncology · 2022 · 90 citations · Full text

Mesenchymal stromal cells plus basiliximab, calcineurin inhibitor as treatment of steroid-resistant acute graft-versus-host disease: a multicenter, randomized, phase 3, open-label trial

Ke Zhao, Ren Lin, Zhiping Fan et al. · Journal of Hematology & Oncology · 2022 · 84 citations · Full text

Haploidentical transplantation compared with matched sibling and unrelated donor transplantation for adults with standard‐risk acute lymphoblastic leukaemia in first complete remission

Lijie Han, Yu Wang, Zhi‐Ping Fan et al. · British Journal of Haematology · 2017 · 81 citations · Full text